陈冬梅, 陈凯, 汪海. 吗啉环和哌嗪环类衍生物的抗血栓作用及其分子机制J. 药学学报, 2003, 38(9): 641-645.
引用本文: 陈冬梅, 陈凯, 汪海. 吗啉环和哌嗪环类衍生物的抗血栓作用及其分子机制J. 药学学报, 2003, 38(9): 641-645.
CHEN Dong-mei, CHEN Kai, WANG Hai. Antithrombotic effects of morpholine and piperazine ring derivatives and their molecular mechanismJ. Acta Pharmaceutica Sinica, 2003, 38(9): 641-645.
Citation: CHEN Dong-mei, CHEN Kai, WANG Hai. Antithrombotic effects of morpholine and piperazine ring derivatives and their molecular mechanismJ. Acta Pharmaceutica Sinica, 2003, 38(9): 641-645.

吗啉环和哌嗪环类衍生物的抗血栓作用及其分子机制

Antithrombotic effects of morpholine and piperazine ring derivatives and their molecular mechanism

  • 摘要: 目的研究吗啉环和哌嗪环类衍生物对血栓形成的影响及分子机制。方法利用小鼠尾动脉血栓模型,观察新化合物对血栓形成的影响。结果化合物MOPMC,2FBMPC,MPTMBC,DMHPPP和PPVP在1.0 mg·kg-1可显著降低成栓率;而结构类似的化合物MAPC,4C3FBMOC,mTBMPC,MONVP和MPNVP对血栓形成均无明显影响;化合物DMHPPP对凝血系统和血小板聚集功能无显著影响,但可升高血浆中t-PA和PGI2含量,降低PAI-1的活性和TXA2的含量。结论吗啉环和哌嗪环类化合物可激活血管内皮细胞乙酰胆碱作用靶标而对抗血栓形成。

     

    Abstract: AimTo investigate the antithrombotic effects of morpholine and piperazine ring derivatives and their mechanisms. MethodsIn isolated rat aorta-precontracted with norepinephrine (NE), the vasodilatory effects of compounds with novel structure were investigated. Mice was given kappa-carrageenin ip and kept at the temperature of (20-21)℃. Results and ConclusionActive candidate compounds including MOPMC, 2FBMPC, MPTMBC, DMHPPP and PPVP were shown to antagonize thrombosis at the dose of 1 mg·kg-1 through activating the endothelial target for acetylcholine; while the contrasting compounds MAPC, 4C3FBMOC, mTBMPC, MONVP and MPNVP showed no significant effect on the tension of isolated aorta strips or significant antithrombotic effects at the same dose. The antithrombotic mechanism of novel compounds is not relevant to hemostatic systems or functions of platelet aggregation directly, but they can promote endothelial cells to release tissue-type plasminogen activator (t-PA) and inhibit the activity of plasminogen activator inhibitor-1 (PAI-1).

     

/

返回文章
返回